Viruses are minimalist pathogens that require a living host to replicate.
Key Steps for Viral Replication:
Invade host (or a part of the host)
Use host resources to replicate
Spread to new host
Evade immune responses
Viruses are significantly smaller than host cells, generally around 20-400 nm, while ribosomes are approximately 25 nm in size.
Infected hosts provide essential resources for the virus’s metabolism and synthesis.
Viruses are not considered "alive"; their effects on the host can range from minimal to fatal.
Hosts can include bacteria, archaea, or eukaryotes.
Host Specificity of Viruses:
No plant viruses infect animals.
Broad specificity: Influenza can infect birds, pigs, and humans.
Narrow specificity: Smallpox infects only humans; Tobacco Mosaic Virus infects plants; Coronaviruses infect human cells.
Specific focus on SARS-CoV-2 (COVID-19) and how it impacts human health.
Infection often leads to severe respiratory illness in humans.
Understanding the mechanism of how the virus enters and affects human cells is crucial for developing treatments.
Viruses are composed of:
Genome: Either DNA or RNA that encodes viral proteins.
Protein Capsid: Serves as a protective container, displaying many geometric shapes (e.g., HPV).
Outer Envelope (optional): A lipid membrane associated with some viruses, such as all coronaviruses.
Viral genomes are typically small, ranging from 3,000 to 300,000 base pairs.
Coronaviruses, like SARS-CoV-2, have a genome of approximately 30,000 bases.
Categories of Viral Genomes:
DNA Viruses: Can be single-stranded or double-stranded.
RNA Viruses: Can be double-stranded, single-stranded, sense, or antisense.
RNA viruses often use specialized enzymes for replication, including Reverse Transcriptase (converts RNA to DNA) and RNA-dependent RNA Polymerase (replicates RNA), crucial for therapeutic drug targeting.
Methods of virus entry into the body include:
HPV: Enters through abrasions in the epithelium.
Influenza and SARS-CoV-2: Inhaled through droplets into the airways.
Viral proteins (either from the envelope or capsid) bind to specific receptors on the host cell.
For SARS-CoV-2, the spike glycoprotein specifically binds to the ACE2 receptor on lung cells, facilitating infection.
After entering the cell, the virus uses the host's cellular machinery to synthesize its proteins and replicate its genome.
The viral RNA is translated into approximately 28 proteins, including the crucial RNA-dependent RNA Polymerase for viral genome replication.
B-cells produce antibodies specific to non-self antigens, including those presented by viruses.
Each B-cell can generate one specific antibody, having around 10 million different antibody genes.
When an antibody binds to a viral antigen, it can neutralize the threat by either marking it for destruction or directly targeting infected cells.
After recovering from infections, such as with SARS-CoV-2, B-cells generate memory cells that survive for years, improving the response to future encounters with the same antigen.
Vaccination: A method to induce immune memory by introducing antigens that prompt a robust immune response. Approved vaccines for SARS-CoV-2 include those containing inactivated virus or mRNA encoding viral proteins.
Potential challenges include managing weak or excessive immune responses and tracking how long memory cells persist.
Viral Structure:
Describe features of viruses, including genome and capsid.
Define RNA-dependent RNA polymerase and Reverse Transcriptase.
Viral Pathogenicity:
Outline how SARS-CoV-2 operates within its host, causing disease.
Immune Response to Viruses:
Explain how the immune system interacts with viruses and how vaccinations help in mitigating viral infections.